Stepped-Care Telehealth for Distress in Rural Cancer Survivors
Status: | Recruiting |
---|---|
Conditions: | Anxiety, Anxiety, Cancer, Cancer, Depression, Insomnia Sleep Studies, Other Indications |
Therapuetic Areas: | Oncology, Psychiatry / Psychology, Other |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 8/4/2018 |
Start Date: | July 19, 2018 |
End Date: | May 2019 |
Contact: | Karen Craver, MT, MHA |
Email: | kcraver@wakehealth.edu |
Phone: | (336) 713-4394 |
Mental health issues in post-treatment adult cancer survivors are associated with multiple
adverse outcomes and may represent a cancer health disparity for rural survivors. The purpose
of this study is to test a stepped-care approach tailored to symptom severity based on recent
American Society of Clinical Oncology guidelines for reducing emotional distress (anxiety
and/or depressive symptoms) and improving secondary outcomes (sleep disturbance, fatigue,
fear of recurrence, quality of life) in rural, post-treatment cancer survivors in community
oncology settings and to examine intervention costs. The resultant intervention will have
great potential for widespread dissemination since it will be manualized, delivered by
telephone, and comprised of modules to allow customized treatments for individuals with
different cancer types.
adverse outcomes and may represent a cancer health disparity for rural survivors. The purpose
of this study is to test a stepped-care approach tailored to symptom severity based on recent
American Society of Clinical Oncology guidelines for reducing emotional distress (anxiety
and/or depressive symptoms) and improving secondary outcomes (sleep disturbance, fatigue,
fear of recurrence, quality of life) in rural, post-treatment cancer survivors in community
oncology settings and to examine intervention costs. The resultant intervention will have
great potential for widespread dissemination since it will be manualized, delivered by
telephone, and comprised of modules to allow customized treatments for individuals with
different cancer types.
Inclusion Criteria:
- Age ≥18 years
- Score ≥10 on the GAD-7 and/or a score ≥8 on the PHQ-9, indicating clinically
significant anxiety or depressive symptoms, respectively.
- Past history of treated Stage I, II, or III (newly diagnosed or recurrent)28,29
breast, colorectal, prostate, gynecologic (to include uterine and cervical) cancers
and non-Hodgkin's lymphoma.
- 6-60 months post-treatment (surgery, chemotherapy, and/or radiation therapy) for
cancer. Time frame applies to most recent completion of treatment if participant had a
cancer recurrence. It is acceptable to be on maintenance or hormonal therapies.
- Residency in a rural zip code defined as below by the Rural-Urban Commuting Areas
(RUCA) Version 3.1. Residential zip codes are assigned an RUCA code based on size of
its largest population center and commuting patterns. Urban: 1.0, 1.1, 2.0, 2.1, 3.0,
4.1, 5.1, 7.1, 8.1, and 10.1 Rural: 4.0, 4.2, 5.0, 5.2, 6.0, 6.1, 7.0, 7.2, 7.3, 7.4,
8.0, 8.2, 8.3, 8.4, 9.0, 9.1, 9.2, 10.0, 10.2, 10.3, 10.4, 10.5, and 10.6
- Must be able to speak and understand English.
- Must have access to a telephone
Exclusion Criteria:
- Current psychotherapy [regular appointment(s) with a psychologist, counselor, or
therapist within the last 30 days].
- Self-reported active alcohol or substance abuse within the last 30 days.
- Past history of prostate cancer or non-Hodgkin's lymphoma with only active
surveillance (i.e., no surgery, chemotherapy, or radiation therapy).
- Diagnosis of a second malignancy (except for non-melanoma skin cancers) after a
previous diagnosis of breast, colorectal, gynecologic cancers and non-Hodgkin's
lymphoma
- Progressive cancer (must be considered no evidence of disease or stable)
- Self -reported history of a diagnosis of dementia from a healthcare provider.
- Global cognitive impairment based on education-adjusted scores on the Telephone
Interview for Cognitive Status-modified
- Self -reported psychotic symptoms in the last 30 days
- Active suicidal ideation (currently reported suicidal plan and intent).
- Any change in psychotropic medications within the last 30 days.
- Hearing loss that would preclude participating in telephone sessions (determined by
brief hearing assessment administered by research staff )
We found this trial at
24
sites
Click here to add this to my saved trials
3105 Magory Drive
Bloomington, Illinois 61704
Bloomington, Illinois 61704
Principal Investigator: Bryan Faller, MD
Click here to add this to my saved trials
Click here to add this to my saved trials
Carterville, Illinois 62918
Principal Investigator: Bryan Faller, MD
Click here to add this to my saved trials
Click here to add this to my saved trials
Decatur, Illinois 62526
Principal Investigator: Bryan Faller, MD
Click here to add this to my saved trials
2300 N Edward St
Decatur, Illinois 62526
Decatur, Illinois 62526
(217) 876-8121
Principal Investigator: Bryan Faller, MD
Decatur Memorial Hospital An American flag bearing only 48 stars waved above Decatur Memorial Hospital...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
336 Home Boulevard
Galesburg, Illinois 61401
Galesburg, Illinois 61401
Principal Investigator: Bryan Faller, MD
Click here to add this to my saved trials
Galesburg, Illinois 61401
Principal Investigator: Bryan Faller, MD
Click here to add this to my saved trials
Kewanee, Illinois 61443
Principal Investigator: Bryan Faller, MD
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
221 NE Glen Oak Ave
Peoria, Illinois 61636
Peoria, Illinois 61636
(309) 672-5522
Principal Investigator: Bryan Faller, MD
Methodist Medical Center of Illinois UnityPoint Health is one of the nation's most integrated health...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
801 N Rutledge St
Springfield, Illinois 62702
Springfield, Illinois 62702
(217) 545-8000
Principal Investigator: Bryan Faller, MD
Phone: 309-243-3618
Southern Illinois University School of Medicine At SIU School of Medicine, research includes biologically oriented...
Click here to add this to my saved trials
Swansea, Illinois 62226
Principal Investigator: Bryan Faller, MD
Click here to add this to my saved trials